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Abstract
Introduction. Acute limb ischemia (ALI) is a severe condition affecting the extremities and the patient’s survival that requires immediate treatment. It can be treated with
either surgical or endovascular revascularization or both (hybrid procedure). It is crucial to evaluate the defect using intraoperative fluoroscopy or angiography in each
case. The review aimed to find out the outcomes of the thrombectomy with intraoperative fluoroscopy for ALI Rutherford IIb.
Method. According to the PRISMA protocol, the literature search proceeded in online databases, i.e., Cochrane, Scopus, PubMed, and EBSCOhost, with no year
limitation on the publication. All articles were screened and critically appraised. Five eligible articles enrolled in this study with 269 patients ALI Rutherford IIb. All
selected articles are cohort studies, including prospective and retrospective.
Results. The endovascular intervention (with intraoperative fluoroscopy assistance) showed lower mortality and morbidity than open thrombectomy – however, no
difference between open and hybrid thrombectomy in mortality rate. In addition, morbidities such as amputation and limb salvage showed no difference significantly
between these interventions. Open thrombectomy has a high risk of mortality and amputation. Meanwhile, the endovascular intervention likely showed a risk of
reocclusion, thus, requiring a conversion to open thrombectomy.
Conclusion. Intraoperative angiography during open thrombectomy may reduce complications of postintervention reocclusion.
Key words: acute limb ischemia, fluoroscopy, intraoperative, Rutherford IIb, thrombectomy

Introduction
Acute limb ischemia (ALI) not solely adversely affects the extremities
but is also life-threatening. It is a severe condition requiring immediate
treatment. The treatment includes surgically, with endovascular
revascularization, or a hybrid procedure. It is important to evaluate the
lesion using fluoroscopy or additional imaging in each case. Considering
the survival and prognosis, if complications occur, a procedure of
amputation may have proceeded.1 The main goal of ALI management
is to limb–save and maintain its function. Revascularization is the first
step to preserving limb viability. However, the procedure is not possible
in some cases.1
The ALI Rutherford IIb case is common in Indonesia that requires an
immediate operative procedure to save the limb and avoid amputation.
The Data National Hospital Discharge Survey in 1988-2007 showed
1.76 million cases of arterial thromboembolism in the lower extremities.
The incidence was 42.4 per 100,000 in 1988-1997 and 23.3 per 100,000
in 1998-2007, with a mortality rate of 8.28% in 1988-1997 and
decreasing to 6.34% in 1998-2007.2,3 To date, the incidence of ALI is
increasing and approaching 1.5 cases per 10,000 per year.4 Risk of the
sacrificed limb was 5-30%, and the mortality was 11-18%.5
Some urgent revascularization is needed in managing these cases, one
of which is a thrombectomy. Fukuda et al. reported the success rate of
revascularization with the conventional endovascular procedures
without thrombolytic agents in 64 treated limbs. Success in 20 patients
with this kind of treatment was 95.5%, while in 42 patients treated with
surgical revascularization was 92.9%.6 Another study by Argyriou et al.

reported that the success rate of hybrid revascularization in 31 patients
was 100%.7
The typical thrombectomy procedure applied at our tertiary hospital
(CMGH) was conventionally using a Fogarty catheter. The treatment
proceeded without intraoperative fluoroscopy. Unfortunately, some
complications or repetition after the initial thrombectomy; thus,
amputation risk increased from 10 to 40%. In addition, Zaraca et al.
found reocclusion after thrombectomy. Those treated without
intraoperative angiography were 10% higher than those treated with
routine intraoperative angiography.8 The review focused on the
necessity of intraoperative fluoroscopy assistance during conventional
thrombectomy for ALI Rutherford IIb.
Methods
In this review, a literature search proceeded in four online databases. i.e.,
Cochrane, Scopus, PubMed, and EBSCOhost. The keywords used was:
((acute limb ischemia)) AND ((Rutherford IIB) OR (Rutherford 2B))
AND ((fluoroscopy) OR (angiography) OR (hybrid) OR
(thrombectomy) OR (thromboembolectomy) OR (embolectomy)).
These include (1) meta-analysis, systematic review, randomized
controlled trial, or cohort study; (2) the subject is ALI Rutherford IIb that
were treated with thrombectomy and intraoperative fluoroscopy; (3) no
limitation of publication year. Excluded articles were: (1)
correspondence, editorial, or commentary, (2) no full text, and (3)
subjects with thrombectomy or previous catheter-directed thrombolysis
(CDT).
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These articles were screened based on title and abstract and then
appraised for validity, importance, and applicability. The appraised
articles were further critically appraised using specific tools: (1) metaanalysis, a systematic review from RCT, and RCT were appraised using
the University of Oxford Centre for Evidence-based Medicine (Oxford
CEBM critical appraisal worksheet) for Systematic Reviews and
Randomized Clinical Trials; and (2) the cohort, case series, and case
report were each appraised using Joanna Briggs Institute, Faculty of
Health and Medical Sciences, University of Adelaide, South Australia,
Checklist for Cohort, Case Series, and Case Reports Studies (critical
appraisal tools). Finally, the level of evidence was determined according
to the Oxford CEBM level of evidence 2011. The literature search
proceeded according to the PRISMA (Figure 1).

Results
Five articles were included in this study through a literature search, as
shown in. the flowcharts presented in figure 1 comprised a cohort study,
including prospective and retrospective. In addition, a critical appraisal
worksheet was drawn in a table in the appendix. A study by Poursina et
al. proceeded with an endovascular intervention only. In contrast, Jungi
et al. performed an open thrombectomy. These two studies did not fit the
eligibility criteria since there were no comparative analyses, but the
subject's measures remain eligible. Poursina et al. reported no
conversion to open thrombectomy in two subjects,9 and consistently,
Jungi et al. reported the outcome of open thrombectomy only.10 To date,
the published comparative studies that focused on endovascular and
open thrombectomy outcomes remain minimal. Thus, should these two
studies be excluded, the review will not reach the baseline outcome of
each procedure. Therefore, the scope and discussion will be limited. For
this reason, the authors decided to include these two studies.

Figure 1. Literature search in accordance to PRISMA protocol found 5 eligible studies.
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Discussion
Frequently, the choice of intervention in ALI Rutherford IIb patients is
mostly open thrombectomy. Genovese et al. reported their study on
managing ALI Rutherford IIb. Of 128 patients who underwent open
thrombectomy, only 30 patients proceeded with endovascular
intervention.11 Likewise, de Athayde al. reported that thirteen patients
underwent open thrombectomy, and only four proceeded with
endovascular intervention (p = 0.003).12 The non–open thrombectomy
is increasing. The treatment in managing ALI Rutherford IIb is not
solely open thrombectomy. Poursina et al. showed that endovascular
intervention might replace the open surgery as the first line in various
Rutherford categories, even though Rutherford III, which was
previously considered, could be revascularized solely with an open
thrombectomy.9
Consideration in choosing an intervention is determined based on the
etiology of ALI. Should it be caused by thrombus, endovascular
intervention (arteriogram with thrombolysis, mechanical
thrombectomy, balloon angioplasty, and stent) is preferred in 50% of
cases. Only 20% required an open thrombectomy (open simple), and
11% had an open complex. Should ALI be caused by embolism, 80%
of subjects proceeded with an open thrombectomy, and 20% proceeded
with endovascular intervention.13 Reports showed that hybrid
interventions remain infrequently carried out, merely in 11% of cases.
However, this intervention has been more frequent recently. This
procedure allows the patient to proceed with both endovascular and
open thrombectomy.14 The requirement for providing hybrid
intervention was the availability of operating room facilities and
competent surgeons to perform open thrombectomy should the non–
open intervention fail. Recently, there has been an increasing demand
for a closed technique. However, it should note that some cases require
an open thrombectomy or open revascularization. For instance, a local
thrombus or embolism of the common femoral artery should be treated
with simple exposure and thromboendarterectomy. In addition, in cases
of ALI Rutherford IIb, a fasciotomy is often required. This case
preferred an open thrombectomy and avoided the use of thrombolytic
agents.9,14
The above studies show that the endovascular and hybrid were the most
chosen without leaving the role of open thrombectomy. However, open
thrombectomy remains the most common choice in some centers to
avoid an unfavorable outcome. This ALI with Rutherford IIb requires
an immediately restored blood flow, so an endovascular intervention is
less recommended.9–14 The most performed endovascular intervention
was the catheter-directed thrombolysis (CDT) type. Meanwhile, open
thrombectomy was more preferred in an open procedure. However, the
lack of single endovascular thrombectomy procedures without
thrombolysis remains unknown. Therefore, it is necessary to discuss the
outcome of each procedure let the surgeon may have a reasonable
consideration to choosing the best intervention for their patients.
Regarding the outcomes, i.e., mortality and morbidity, many studies
have assessed outcomes based on overall survival, thirty days to oneyear survival rate, the major amputations prevalence, limb salvage, and
length of hospital stays. Regardless of the choice of intervention,
Hemingway et al.,13 showed that the mortality rate was 2%.13 However,
Poursina et al.9 reported increasing mortality to 23.1% in those who
proceeded with endovascular intervention. Somehow the increased
mortality was thought to be influenced by the embolic-type ALI.9 So far,
some studies have shown that open thrombectomy had higher long-term
mortality and amputation than endovascular intervention.11 A
comparative study reported a higher overall survival rate in the
endovascular group and higher thirty-day mortality in the open
thrombectomy group.12 Meanwhile, the survival rate in the hybrid
39
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procedure was reasonable.7 de Athayde et al.,12 who compared the open
thrombectomy group vs. the endovascular group, found a higher limb
salvage in the open thrombectomy group.12 While as, Jungi et al.,10
found the long-term outcomes of limb salvage better if immediate
revascularization proceeded with an open thrombectomy, especially in
ALI Rutherford IIb.
Severe cases categorized as Rutherford III may be treated with
revascularization, although those in the borderline between category IIb
or III should be subjectively selected.10 Cases with ALI of Rutherford
IIb could be treated by hybrid revascularization. The endovascular
access is proximally or distally to the open thrombectomy site. With this
treatment, the six–month overall patency and limb salvage were
reasonable.7 Hemingway et al.,13 found that primary amputation and
limb salvage were not associated with the intervention chosen. Open,
closed, or hybrid interventions showed a higher successful limb salvage
in Rutherford IIb. Of 21% failed and had proceeded with amputation.
Primary amputation is associated with ischemia due to thrombotic
occlusion but not embolic. Morbidity is also seen in the difference in
hospital discharge between ALI Rutherford IIb patients discharged
compared to those referred to a skilled care facility.13
All the above studies showed that the outcome of ALI Rutherford IIb
was reasonable. Endovascular intervention is superior in the mortality
and morbidity rate. Although de Athayde et al.,12 Jungi et al.,10 Davis et
al.,14 and Argyriou et al.,7 showed that open thrombectomy is superior
for limb salvage. However, Hemingway et al.13 reported no difference
in outcomes between open, hybrid, and endovascular thrombectomy in
amputation rates and limb salvage.7,10,12–14 However, endovascular
intervention with intraoperative angiography is the first-line approach.
Operators and resources should also be prepared to convert into an open
thrombectomy procedure when the endovascular intervention fails. The
need for a hybrid operating room (which can perform both endovascular
and open thrombectomy assisted by intraoperative angiography) was an
issue that deserves consideration.
Regarding intraoperative fluoroscopy or angiography, Poursina et al.
reported intraoperative imaging and ultrasonography (USG) that guides
the catheter. Ultrasound is sufficient to assess the thrombus, leading the
surgeon to decide.9 Intraoperative angiography was beneficial in
determining the reduced patency flow in the blood vessels, which may
lead immediately to a primary major amputation.10 Intraoperative
angiography helps assess the success of revascularization based on
vessel runoff. When the test results did not reveal a patent vessel runoff
with bypass flow to the leg only through collaterals, this situation
indicated unsuccessful revascularization.10
The reocclusion within 24 months after thrombectomy or embolectomy
is lower in those who proceeded with routine intraoperative angiography
than in selective intraoperative angiography. However, there was no
difference in amputation and mortality rates between the two types of
angiographies. However, there was no difference in amputation and
mortality rates between the two types of angiographies. Should it be
compared to selective angiography, a routine angiography known to
increase intraoperative reintervention (53.4% vs. 29.9%). Intraoperative
angiography was associated with an increase in the procedure's duration
to remove residual lesions.8 In upper limb ALI, routine angiography
decreased the reocclusion rate 24 months after embolectomy. However,
the mortality between routine and selective intraoperative angiography
was not significantly different. The rate of intraoperative reintervention
was also higher at routine angiography, reaching 26%.15 A complete
angiogram should be performed before the patient is discharged from
the operating room. It helped detect incomplete procedures that require
reintervention. Regardless of the occlusion site, failure to identify and
treat the thrombus can lead to incomplete revascularization and recurrent

thrombosis. Patients who underwent selective angiography had a
reocclusion hazard ratio 5.44 times higher than patients who underwent
routine intraoperative angiography.8,15
Complete angiography helped identify residual thrombus and identify
incomplete recanalization of the proximal artery because of adherence
of the remaining thrombus to the arterial wall. In addition, it detected the
occurrence of steno-occlusive lesions after clot removal.16,17 European
Society for Vascular Surgery (ESVS) 2020 recommends complete
angiography (1C recommendation) in the treatment of open and
endovascular thrombectomy.18
Parson firstly introduced the use of intraoperative angiography or
fluoroscopy in 1996. Parson was the first who performed a combination
of surgical and endovascular techniques as a treatment for ALI patients.
Intraoperative angiography helped minimize arterial damage and blood
loss during clot clearance, increase the accuracy of site identification, and
manage arterial occlusion lesions. Since then, the recommendation for
routine post-thromboembolectomy angiography has been increasingly
adopted. Interestingly, intraoperative angiography plays an important
role in hybrid intervention. It served as additional guidance in
endovascular technique. However, to date, intraoperative angiography
in clinical practice remains infrequent.16
The contrast used in angiographic procedures was iodine which was
nephrotoxic. Thus, postoperatively, patients should be proceeded with
dialysis and have renal function monitoring. There were successful case
reports of using carbon dioxide as a substitution for iodine contrast. The
advantages of carbon dioxide were safety and non-nephrotoxicity. It
provides both diagnostic and therapeutic modalities, but its application
has not been common in clinical settings recently. The use of carbon
dioxide contrast might be considered in ALI patients with borderline
renal function to reduce the risk of short-term and long-term dialysis.19
This idea was later supported by the study of Kawasaki et al., who
performed angiographic-guided endovascular intervention. That study
compared the effects of carbon dioxide contrast and iodine contrast in
ALI patients. As a result, both contrasts were successful without any
major complications. Arteriograms using carbon dioxide were cheap,
easy, and safe for ALI patients with CKD who will undergo
endovascular intervention.20
All studies discussed showed evidence that intraoperative fluoroscopy
or angiography implementation should be more intense. It is preferable
to perform it in a hybrid operating room or an operating room with a Carm to optimize ALI patients' management. We advise this procedure
led by a team of clinicians who are ready and able to perform an
endovascular intervention, even a conversion to open thrombectomy if
needed.18
Conclusions
Mortality and morbidity were lower in ALI Rutherford IIb treated with
endovascular intervention with intraoperative fluoroscopy assistance
than open thrombectomy. However, the mortality rate was not different
between open and hybrid thrombectomy. In addition, morbidities such
as amputation and limb salvage were not significantly different between
the type of intervention performed.
Open thrombectomy has a high risk of mortality and amputation.
Meanwhile, the endovascular intervention risks reocclusion, so
conversion to open thrombectomy is required. The role of intraoperative
angiography in open thrombectomy provides a better outcome in ALI
Rutherford IIb patients. Open thrombectomy with intraoperative
angiography can also reduce complications of post-intervention
reocclusion.
33
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